
Exponent (EXPO) Stock Forecast & Price Target
Exponent (EXPO) Analyst Ratings
Bulls say
Exponent Inc has demonstrated solid financial performance, with a year-over-year increase in net revenues of 1% to $113.9 million and a notable 14% growth in earnings per share (EPS) to $0.57. The utilization rate rose to 75% in the latest quarter, up from 69% a year ago, indicating improved efficiency and productivity within the company's consulting segments, which are primarily driven by engineering services. Additionally, the projected EBITDA margin range for the third quarter increased significantly to between 26.75% and 27.5%, surpassing analyst expectations and reflecting enhanced profitability, which supports a positive financial outlook for the company.
Bears say
Exponent Inc's recent profitability figures fell short of market expectations, with an EBITDA of $30.5 million versus the consensus of $31.7 million, which reflects a margin compression of 80 basis points year-over-year due to post-pandemic expense normalization and reduced utilization rates. The company's forward-looking guidance indicates a bleak outlook, forecasting flat to low-single digit revenue growth for both the first quarter of 2024 and for the full year, significantly below consensus estimates which anticipate a modest increase. Additionally, a projected decline in average headcount and persistently weaker demand, particularly in the Consumer Electronics sector, further supports concerns regarding Exponent's revenue trajectory and overall financial stability.
This aggregate rating is based on analysts' research of Exponent and is not a guaranteed prediction by Public.com or investment advice.
Exponent (EXPO) Analyst Forecast & Price Prediction
Start investing in Exponent (EXPO)
Order type
Buy in
Order amount
Est. shares
0 shares